Illumina SVP Gregory Heath Sells 1,875 Shares (ILMN)
Illumina (NASDAQ:ILMN) SVP Gregory Heath sold 1,875 shares of Illumina stock in a transaction dated Thursday, October 17th. The shares were sold at an average price of $82.09, for a total transaction of $153,918.75. Following the completion of the sale, the senior vice president now directly owns 26,740 shares of the company’s stock, valued at approximately $2,195,087. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
A number of research firms have recently commented on ILMN. Analysts at Wedbush raised their price target on shares of Illumina from $60.00 to $65.00 in a research note to investors on Tuesday, October 15th. They now have a “neutral” rating on the stock. Separately, analysts at Bank of America Corp. reiterated a “buy” rating on shares of Illumina in a research note to investors on Friday, September 27th. They now have a $90.00 price target on the stock. Finally, analysts at Goldman Sachs Group Inc. raised their price target on shares of Illumina from $73.00 to $74.00 in a research note to investors on Friday, September 27th. They now have a “neutral” rating on the stock. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and eight have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $74.96.
Illumina (NASDAQ:ILMN) traded up 0.41% on Monday, hitting $81.76. 2,133,463 shares of the company’s stock traded hands. Illumina has a 52-week low of $44.78 and a 52-week high of $85.81. The stock’s 50-day moving average is $80.70 and its 200-day moving average is $73.10. The company has a market cap of $10.230 billion and a P/E ratio of 95.80.
Illumina (NASDAQ:ILMN) last posted its quarterly earnings results on Monday, October 21st. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.05. The company had revenue of $357.00 million for the quarter, compared to the consensus estimate of $343.42 million. During the same quarter in the previous year, the company posted $0.41 earnings per share. The company’s revenue for the quarter was up 24.9% on a year-over-year basis. On average, analysts predict that Illumina will post $1.72 earnings per share for the current fiscal year.
Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.